Raleigh, NC, United States of America

Scott H Dickerson

This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott H Dickerson. Retrieved from https://idiyas.com/inventor/scott-h-dickerson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott H. Dickerson: Innovator in Pharmaceutical Compounds

Introduction

Scott H. Dickerson is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thymidylate synthase inhibitors. His research and inventions have the potential to impact medical treatments significantly.

Latest Patents

Scott H. Dickerson holds 1 patent related to pharmaceutical compounds. His patent focuses on novel benzoquinazoline thymidylate synthase inhibitors, which are crucial for developing new pharmaceutical formulations and their applications in medicine.

Career Highlights

Scott is associated with Burroughs Wellcome Co., where he has been instrumental in advancing pharmaceutical research. His work has contributed to the understanding and development of new therapeutic agents.

Collaborations

Throughout his career, Scott has collaborated with esteemed colleagues, including Julius Vass Johnson and William Pendergast. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Scott H. Dickerson exemplifies the spirit of innovation in the pharmaceutical industry, with his work paving the way for future advancements in medicine. His contributions are a testament to the importance of research and collaboration in developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…